Case Name |
Date Filed |
Judge |
Drug |
Patent No(s). |
Otsuka Pharm. Co., Ltd. v. Optimus Pharma Pvt. Ltd., 20-1332 (D. Del.) |
Oct. 1, 2020 |
Hon. Leonard P. Stark |
Rexulti® (brexipiprazole tablets) |
RE48,059 |
Vanda Pharms. Inc. v. Apotex Inc., 20-1333 (D. Del.) |
Oct. 1, 2020 |
Hon. Colm F. Connolly |
Hetlioz® (tasimelteon capsules) |
10,610,510
10,610,511 |
Otsuka Pharm. Co., Ltd. v. MSN Pharms. Inc., 20-1334 (D. Del.) |
Oct. 1, 2020 |
Hon. Colm F. Connolly |
Hetlioz® (tasimelteon capsules) |
10,610,510
10,610,511 |
Otsuka Pharm. Co., Ltd. v. Ajanta Pharma Ltd., 20-1335 (D. Del.) |
Oct. 1, 2020 |
Hon. Leonard P. Stark |
Rexulti® (brexipiprazole tablets) |
RE48,059 |
UCB, Inc. v. Sunshine Lake Pharma Co., Ltd., 20-1343 (D. Del.) |
Oct. 2, 2020 |
Hon. Colm. F. Connolly |
Briviact® (brivaracetam tablets) |
6,784,197
6,911,461
8,492,416 |
Allergan USA, Inc. v. Hetero Labs Ltd., 20-1344 (D. Del.) |
Oct. 2, 2020 |
Hon. Richard G. Andrews |
Viberzi® (eluxadoline tablets) |
7,741,356 |
Actelion Pharms. Ltd. v. Laurus Labs Ltd., 20-13967 (D.N.J.) |
Oct. 5, 2020 |
Hon. Freda L. Wolfson |
Opsumit® (macitentan tablets) |
7,094,781 |
Almirall, LLC v. Torrent Pharms. Ltd., 20-1373 (D. Del.) |
Oct. 9, 2020 |
Hon. Maryellen Noreika |
Aczone® Gel (dapsone) |
9,517,219 |
Celgene Corp. v. Hetero Labs Ltd., 20-14389 (D.N.J.) |
Oct. 13, 2020 |
Hon. Susan D. Wigenton |
Revlimid® (lenalidomide capsules) |
7,977,357
8,193,219 |
Pfizer Inc. v. Alembic Pharms., Inc., 20-1392 (D. Del.) |
Oct. 16, 2020 |
Hon. Colm F. Connolly |
Ibrance® (palbociclib capsules) |
10,723,730 |
Pfizer Inc. v. Cipla USA Inc., 20-1393 (D. Del.) |
Oct. 16, 2020 |
Hon. Colm F. Connolly |
Ibrance® (palbociclib capsules) |
10,723,730 |
Pfizer Inc. v. Mylan Pharms. Inc., 20-1395 (D. Del.) |
Oct. 16, 2020 |
Hon. Colm F. Connolly |
Ibrance® (palbociclib capsules) |
10,723,730 |
Pfizer Inc. v. Zydus Pharms. (USA) Inc., 20-1396 (D. Del.) |
Oct. 16, 2020 |
Hon. Colm F. Connolly |
Ibrance® (palbociclib capsules) |
10,723,730 |
Pfizer Inc. v. Zydus Pharms. (USA) Inc., 20-14580 (D.N.J.) |
Oct. 16, 2020 |
Hon. Renee Marie Bumb |
Ibrance® (palbociclib capsules) |
10,723,730 |
Pfizer Inc. v. Mylan Pharms. Inc., 20-0244 (N.D.W.V.) |
Oct. 16, 2020 |
Hon. Thomas S. Kleeh |
Ibrance® (palbociclib capsules) |
10,723,730 |
Pfizer Inc. v. Sun Pharm. Indus., Ltd, 20-1407 (D. Del.) |
Oct. 20, 2020 |
Hon. Colm F. Connolly |
Ibrance® (palbociclib capsules) |
10,723,730 |
Pfizer Inc. v. Sun Pharm. Indus., Ltd, 20-14717 (D.N.J.) |
Oct. 20, 2020 |
Hon. Renee Marie Bumb |
Ibrance® (palbociclib capsules) |
10,723,730 |
Dermira, Inc. v. Perrigo Pharma Int’l DAC, 20-1413 (D. Del.) |
Oct. 21, 2020 |
Hon. Colm F. Connolly |
Qbrexza® (glycopyrronium cloth) |
8,618,160
9,744,105
10,052,267
8,859,610
9,259,414
10,004,717
10,543,192
10,548,875 |
Teva Branded Pharm. Products R&D, Inc. v. Aurobindo Pharma Ltd., 20-14833 (D.N.J.) |
Oct. 22, 2020 |
Hon. Madeline Cox Arleo |
Qvar® (beclomethasone dipropionate inhalation aerosol) |
9,463,289
9,808,587
10,022,509
10,022,510
10,086,156
10,561,808
10,695,512 |
Galderma Labs., L.P. v. Zydus Pharms. (USA) Inc., 20-14857 (D.N.J.) |
Oct. 22, 2020 |
Hon. Freda L. Wolfson |
Epiduo® Forte (adapalene / benzoyl peroxide gel) |
8,936,800
9,814,690
8,785,420
8,703,820
9,387,187
8,445,543 |
Otsuka Pharm. Co., Ltd. v. Teva Pharms. USA, Inc., 20-1423 (D. Del.) |
Oct. 23, 2020 |
Hon. Leonard P. Stark |
Rexulti® (brexipiprazole tablets) |
RE48,059 |
Novartis Pharms. Corp. v. Aurobindo Pharma Ltd., 20-1426 (D. Del.) |
Oct. 23, 2020 |
Hon. Leonard P. Stark |
Xiidra® (lifitegrast ophthalmic solution) |
7,314,938
7,745,460
7,790,743
7,928,122
9,216,174
10,124,000
8,084,047
8,592,450
8,168,655
8,367,701
9,447,077
8,927,574
9,353,088
9,890,141
9,085,553 |
Otsuka Pharm. Co., Ltd. v. MSN Labs. Pvt. Ltd., 20-1428 (D. Del.) |
Oct. 23, 2020 |
Hon. Leonard P. Stark |
Rexulti® (brexipiprazole tablets) |
RE48,059 |
Teva Branded Pharm. Products R&D, Inc. v. Cipla Ltd., 20-14890 (D.N.J.) |
Oct. 23, 2020 |
Hon. Madeline Cox Arleo |
Qvar® (beclomethasone dipropionate inhalation aerosol) |
10,695,512 |
TherapeuticsMD, Inc. v. Amneal Pharms., Inc., 20-14933 (D.N.J.) |
Oct. 23, 2020 |
Hon. Freda L. Wolfson |
Bijuva® (estradiol / progesterone capsules) |
10,806,740 |
Allergan USA, Inc. v. Sun Pharm. Indus. Ltd., 20-1479 (D. Del.) |
Oct. 29, 2020 |
Hon. Richard G. Andrews |
Viberzi® (eluxadoline tablets) |
7,741,356 |
Fresenius Kabi USA, LLC v. Custopharm, Inc., 20-3254 (D. Col.) |
Oct. 30, 2020 |
Hon. Michael E. Hegarty |
levothyroxine sodium for injection |
9,782,376
10,398,669 |
Fresenius Kabi USA, LLC v. Custopharm, Inc., 20-15342 (D.N.J.) |
Oct. 30, 2020 |
Hon. Susan D. Wigenton |
levothyroxine sodium for injection |
9,782,376
10,398,669 |
Fresenius Kabi USA, LLC v. Custopharm, Inc., 20-1091 (D. Col.) |
Oct. 30, 2020 |
Hon. Lee Yeakel |
levothyroxine sodium for injection |
9,782,376
10,398,669 |
Merck Sharp & Dohme Corp. v. Ajanta Pharma Ltd., 20-1496 (D. Del.) |
Nov. 4, 2020 |
Hon. Richard G. Andrews |
Janumet® (sitagliptin phosphate / metformin HCl tablets) |
7,326,708 |
Otsuka Pharm. Co., Ltd. v. Prinston Pharm. Inc., 20-1502 (D. Del.) |
Nov. 6, 2020 |
Hon. Leonard P. Stark |
Rexulti® (brexpiprazole tablets) |
RE48,059 |
Pfizer Inc. v. Aurobindo Pharma, Ltd., 20-1528 (D. Del.) |
Nov. 13, 2020 |
Hon. Colm F. Connolly |
Ibrance® (palbociclib capsules) |
10,723,730 |
Pfizer Inc. v. Dr. Reddy’s Labs., Inc., 20-1530 (D. Del.) |
Nov. 13, 2020 |
Hon. Colm F. Connolly |
Ibrance® (palbociclib capsules) |
10,723,730 |
Otsuka Pharm. Co., Ltd. v. Hetero Labs Ltd., 20-1531 (D. Del.) |
Nov. 13, 2020 |
Hon. Leonard P. Stark |
Rexulti® (brexpiprazole tablets) |
RE48,059 |
Pfizer Inc. v. Dr. Reddy’s Labs., Inc., 20-16117 (D. Del.) |
Nov. 13, 2020 |
Hon. Renee Marie Bumb |
Ibrance® (palbociclib capsules) |
10,723,730 |
Sanofi-Aventis U.S. LLC v. Hong Kong King-Friend Industrial Co. Ltd., 20-1547 (D. Del.) |
Nov. 17, 2020 |
Hon. Richard G. Andrews |
Jevtana® Kit (cabazitaxel for injection) |
10,583,110
10,716,777 |
Otsuka Pharm. Co., Ltd. v. Aurobindo Pharma Ltd., 20-1581 (D. Del.) |
Nov. 23, 2020 |
Hon. Leonard P. Stark |
Rexulti® (brexpiprazole tablets) |
RE48,059 |
Boehringer Ingelheim Pharms. Inc. v. Sun Pharm. Indus. Ltd., 20-1585 (D. Del.) |
Nov. 23, 2020 |
Hon. Colm F. Connolly |
Trijardy XR® (empagliflozin / linagliptin / metformin extended-release tablets) |
7,579,449 |
Astellas Pharma Inc. v. Sandoz Inc., 20-1589 (D. Del.) |
Nov. 24, 2020 |
Hon. Joseph F. Bataillon |
Myrbetriq® (mirabegron extended-release tablets) |
10,842,780 |
Otsuka Pharm. Co., Ltd. v. Zenara Pharma Private Ltd., 20-1599 (D. Del.) |
Nov. 24, 2020 |
Hon. Leonard P. Stark |
Rexulti® (brexpiprazole tablets) |
RE48,059 |
Adverio Pharma GmbH v. MSN Labs. Private Ltd., 20-1617 (D. Del.) |
Nov. 25, 2020 |
Hon. Leonard P. Stark |
Adempas® (riociguat tablets) |
10,662,188 |
Amarin Pharma, Inc. v. Hikma Pharms. USA Inc., 20-1630 (D. Del.) |
Nov. 30, 2020 |
Hon. Richard G. Andrews |
Vascepa® (icosapent ethyl capsules) |
9,700,537
8,642,077
10,568,861 |
TherapeuticsMD, Inc. v. Teva Pharms. USA, Inc., 20-17496 (D.N.J.) |
Nov. 30, 2020 |
Hon. Brian R. Martinotti |
Imvexxy® (estradiol vaginal insert) |
10,806,697
10,835,487 |
Eli Lilly and Co. v. Shilpa Medicare Ltd., 20-3132 (S.D. Ind.) |
Dec. 4, 2020 |
Hon. Tanya Walton Pratt |
Alimta® (pemetrexed for injection) |
7,772,209 |
Par Pharm., Inc. v. Eagle Pharms. Inc., 20-18319 (D.N.J.) |
Dec. 7, 2020 |
Hon. Brian R. Martinotti |
Vasostrict® (vasopressin for injection) |
10,844,435 |
Par Pharm., Inc. v. Amneal EU, Ltd., 20-18322 (D.N.J.) |
Dec. 7, 2020 |
Hon. Brian R. Martinotti |
Vasostrict® (vasopressin for injection) |
10,844,435 |
Par Pharm., Inc. v. Dr. Reddy’s Labs., Inc., 20-18328 (D.N.J.) |
Dec. 7, 2020 |
Hon. Brian R. Martinotti |
Vasostrict® (vasopressin for injection) |
10,844,435 |
Par Pharm., Inc. v. Aurobindo Pharma U.S.A., Inc., 20-18334 (D.N.J.) |
Dec. 7, 2020 |
Hon. Brian R. Martinotti |
Vasostrict® (vasopressin for injection) |
10,844,435 |
Merck Sharp & Dohme B.V. v. Teva Pharms. USA, Inc., 20-18972 (D.N.J.) |
Dec. 14, 2020 |
Hon. Claire C. Cecchi |
Bridion® (sugammadex for injection) |
RE44,733 |
Acrotech Biopharma LLC v. Alembic Global Holding SA, 20-19295 (D.N.J.) |
Dec. 15, 2020 |
Hon. Freda L. Wolfson |
Evomela® (captisol®-enabled melphalan HCl for injection) |
10,864,183 |
Bausch Health Ireland Ltd. v. Lupin Ltd., 20-19379 (D.N.J.) |
Dec. 16, 2020 |
Hon. Renee Marie Bumb |
Plenvu® (polyethylene glycol / sodium ascorbate / sodium sulfate / ascorbic acid / sodium chloride / potassium chloride oral solution) |
10,780,112
10,792,306 |
Galderma Labs., L.P. v. Zydus Pharms. (USA) Inc., 20-19578 (D.N.J.) |
Dec. 17, 2020 |
Hon. Renee Marie Bumb |
Soolantra® (ivermectin cream) |
9,089,587
9,233,117
9,233,118
9,782,425
10,206,939 |
Merz Pharms., LLC v. Aurobindo Pharma Ltd., 20-1760 (D. Del.) |
Dec. 23, 2020 |
Hon. Richard G. Andrews |
Cuvposa® (glycopyrrolate oral solution) |
7,638,552
7,816,396 |
Otsuka Pharm. Co., Ltd. v. Zydus Pharms. (USA) Inc., 20-1763 (D. Del.) |
Dec. 23, 2020 |
Hon. Leonard P. Stark |
Rexulti® (brexpiprazole tablets) |
RE48,059 |
Otsuka Pharm. Co., Ltd. v. Zydus Pharms. (USA) Inc., 20-20269 (D.N.J.) |
Dec. 23, 2020 |
Hon. Michael A. Shipp |
Rexulti® (brexpiprazole tablets) |
RE48,059 |
Eagle Pharms., Inc. v. Shilpa Medicare Ltd., 20-20270 (D.N.J.) |
Dec. 23, 2020 |
Hon. John Michael Vazquez |
Pemfexy® (pemetrexed for injection) |
9,604,990 |
Merz Pharms., LLC v. Aurobindo Pharma Ltd., 20-20346 (D.N.J.) |
Dec. 28, 2020 |
Hon. Freda L. Wolfson |
Cuvposa® (glycopyrrolate oral solution) |
7,638,552
7,816,396 |